Baseline sleep parameters | | | |
TST min | 0±0.002 (−0.005–0.005) | 1805 | 0.971 |
Sleep efficiency % | 0.002±0.003 (−0.003–0.01) | 1805 | 0.543 |
N3 sleep % | −0.005±0.006 (−0.018–0.007) | 1805 | 0.454 |
REM sleep % | 0.001±0.04 (−0.007–0.007) | 1805 | 0.879 |
Arousal index events·h−1 | 0.001±0.018 (−0.034–0.037) | 1805 | 0.938 |
Mean SpO2 % | 0.004±0.012 (−0.002–0.034) | 1805 | 0.304 |
Lowest SpO2 % | 0.004±0.015 (−0.027–0.033) | 1805 | 0.762 |
3% ODI events·h−1 | 0.005±0.039 (−0.067–0.089) | 1802 | 0.887 |
Time with SpO2 <90% % | 0.018±0.006 (0.008–0.033) | 1784 | 0.008 |
Follow-up cardiometabolic parameters | | | |
Waist circumference cm | 0.072±0.022 (0.029–0.118) | 1805 | 0.002 |
SBP mmHg | 0.021±0.016 (−0.014–0.053) | 1802 | 0.207 |
DBP mmHg | 0.006±0.016 (−0.028–0.037) | 1805 | 0.748 |
Total cholesterol mmol·L−1 | −0.006±0.006 (−0.019–0.004) | 1805 | 0.31 |
HDL cholesterol mmol·L−1 | 0.009±0.013 (−0.016–0.034) | 1805 | 0.45 |
LDL cholesterol mmol·L−1 | −0.006±0.005 (−0.018–0.002) | 1798 | 0.243 |
Triglycerides mmol·L−1 | 0.013±0.022 (−0.023–0.066) | 1805 | 0.447 |
Fasting glucose mmol·L−1 | 0.037±0.02 (0–0.076) | 1804 | 0.033 |
Fasting insulin pmol·L−1 | 0.05±0.016 (0.020–0.081) | 1783 | 0.002 |
HOMA-IR | 0.053±0.016 (0.022–0.083) | 1781 | 0.001 |
hs-CRP nmol·L−1 | 0.006±0.005 (−0.001–0.022) | 1669 | 0.187 |